SLC9A1 Binding mTOR Signaling Pathway-Derived Risk Score Predicting Survival and Immune in Clear Cell Renal Cell Carcinoma

Figure 1

SLC9A1 is lowly expressed in ccRCC samples. (a) Expression of SLC9A1 in ccRCC cancer tissues and normal tissues in TCGA database. (b) qRT-PCR analysis of SLC9A1 in RCC cells vs. human normal renal cells (293T and HK-2). (c) Comparison of SLC9A1 expression between samples with or without SNV mutation. (d) Comparison of SLC9A1 expression between samples with or without CNV mutation. Note: SNV: single nucleotide variants; CNV: copy number variation. , , , and .

(a)

(b)

(c)

(d)